U.S. Retail Pharmacy De-identified Health Data Market Size, Share & Trends Analysis Report By Dataset Type (DSCSA Data, Market Basket Data, Inventory Data, Prior Authorization Data), And Segment Forecasts, 2025 - 2030

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Estimates And Forecast Timeline
                   1.2 Objectives
                       1.2.1 Objective - 1
                       1.2.2 Objective - 2
                   1.3 Segment Definitions
                       1.3.1 DATASET TYPE
                   1.4 Research Methodology
                       1.4.1 DSCSA (DRUG Supply Chain Security Act): Research Scope And Assumption
                           1.4.1.1 Volume Estimation: DSCSA De-identified Data
                           1.4.1.2 CAGR Calculation (2025-2030)
                       1.4.2 Prior Authorization: Research Scope And Assumption
                           1.4.2.1 Volume Estimation: Prior Authorization Data
                           1.4.2.2 CAGR Calculation (2025-2030)
                       1.4.3 Market Basket Data: Research Scope And Assumption
                           1.4.3.1 Volume Estimation: Market Basket Data
                           1.4.3.2 CAGR Calculation (2025-2030)
                       1.4.4 Episodic Data / Pharmacy Rx Claims Data: Research Scope And Assumption
                       1.4.5 Inventory Data: Research Scope And Assumption
                           1.4.5.1 Market Share and Assumption
                       1.4.6 Information Procurement
                           1.4.6.1 Purchased database
                           1.4.6.2 GVR’S internal database
                           1.4.6.3 Primary research
                           1.4.6.3.1 Details of the primary research
                   1.5 Information or Data Analysis
                       1.5.1 Data Analysis Models
                   1.6 Market Formulation & Validation
                   1.7 List of Secondary Sources
                   1.8 List of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Dataset Type - Segment Snapshot
                   2.3 Competitive Landscape Snapshot
Chapter 3 Industry Outlook - Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Global Market Outlook
                   3.2 Market Dynamics
                       3.2.1 Outlook Of Key Drivers And Related Insights By Dataset Type
                       3.2.2 Market Driver Analysis
                           3.2.2.1 Increasing demand for real-world evidence (RWE) and real-world data (RWD)
                           3.2.2.2 Favorable regulatory support for drug supply chain transparency (DSCSA Compliance)
                           3.2.2.3 Growth of value-based care and outcome-based reimbursement models
                       3.2.3 Market Restraint Analysis
                           3.2.3.1 Stringent Privacy regulations and legal risk exposure
                           3.2.3.2 Lack of data quality and data standardization
                       3.2.4 Market Opportunity Analysis
                           3.2.4.1 Integration with digital health, AI, and analytics platforms
                       3.2.5 Market Challenge Analysis
                           3.2.5.1 Ethical concerns and public distrust in data commercialization
                   3.3 Buyer Analysis
                   3.4 Regulatory Trends
                   3.5 U.S. Retail Pharmacy de-identified health data market (Specific to the Five Datasets - Retail Pharmacy as Seller): By Dataset Type Level Pricing Model details
                       3.5.1 Drug Supply Chain Security Data (Dscsa): (Type 1 Segment) Overall Level Pricing Model Structure And Related Analysis
                           3.5.1.1 Pricing Model Overview
                               3.5.1.1.1 Model 1: Compliance-Tiered Licensing (Most Common)
                               3.5.1.1.2 Model 2: Subscription-Based Access to Serialized Data Streams
                               3.5.1.1.3 Model 3: Project-based or On-demand Query Models
                           3.5.1.2 Price Range Analysis
                               3.5.1.2.1 Retail Pharmacies as Sellers Example: CVS Health (ExtraCare Insights Platform)
                               3.5.1.2.2 Retail Pharmacies as Sellers Example: Walgreens
                       3.5.2 Market Basket Data: (Type 1 Segment) Overall Level Pricing Model Structure And Related Analysis
                           3.5.2.1 Pricing Model Overview
                               3.5.2.1.1 Model 1: Tiered Pricing Model (Most Common) (By Data Volume and Granularity)
                               3.5.2.1.2 Model 2: Subscription-Based Access
                               3.5.2.1.3 Model 3: Pay-per-Use or Custom Reports
                           3.5.2.2 Price Range Analysis
                               3.5.2.2.1 Retail Pharmacies as Sellers Example: CVS Health (ExtraCare Insights Platform)
                               3.5.2.2.2 Retail Pharmacies as Sellers Example: Walgreens (Retail Analytics + Loyalty Program Data)
                               3.5.2.2.3 Retail Pharmacies as Sellers Example: Rite Aid (Retail Pharmacy Analytics)
                       3.5.3 Inventory Data: (Type 1 Segment) Overall Level Pricing Model Structure And Related Analysis
                           3.5.3.1 Pricing Model Overview
                               3.5.3.1.1 Model 1: Tiered Pricing Model (By Data Freshness and Geographic Depth)
                               3.5.3.1.2 Model 2: Subscription-Based Access Data Feeds
                               3.5.3.1.3 Model 3: Pay-per-Use or Targeted Alert Modules
                           3.5.3.2 Price Range Analysis
                               3.5.3.2.1 Retail Pharmacies as Sellers Example: CVS Health
                               3.5.3.2.2 Retail Pharmacies as Sellers Example: Walgreens Boots Alliance
                       3.5.4 Prior Authorization Data: (Type 1 Segment) Overall Level Pricing Model Structure And Related Analysis
                           3.5.4.1 Pricing Model Overview
                               3.5.4.1.1 Model 1: Event-based Data Feed Pricing (Most Common)
                               3.5.4.1.2 Model 2: Subscription + Dashboard Access
                               3.5.4.1.3 Model 3: Formulary Access Strategy Packages
                           3.5.4.2 Price Range Analysis
                               3.5.4.2.1 Retail Pharmacies as Sellers Example: CVS Health (Caremark (PBM arm) and MinuteClinic)
                               3.5.4.2.2 Retail Pharmacies as Sellers Example: Walgreens
                       3.5.5 Episodic Data / Pharmacy Rx Claims Data: (Type 1 Segment) Overall Level Pricing Model Structure And Related Analysis
                           3.5.5.1 Pricing Model Overview
                               3.5.5.1.1 Model 1: De-Identified Episodic Journey Files (Static Delivery)
                               3.5.5.1.2 Model 2: Subscription-Based +Dashboard Or API
                               3.5.5.1.3 Model 3: Custom Value-Based Care Packages
                           3.5.5.2 Price Range Analysis
                               3.5.5.2.1 Retail Pharmacies as Sellers Example: CVS Health MinuteClinic and HealthHUBs
                               3.5.5.2.2 Retail Pharmacies as Sellers Example: Walgreens Health Corners
                   3.6 Industry Analysis Tools
                       3.6.1 Porter’s Five Forces Analysis
                       3.6.2 Pestle Analysis
                   3.7 Retail-Pharmacy Specific Trends
                   3.8 Technological Advancements
                   3.9 COVID-19 Impact Analysis
Chapter 4 U.S. Retail Pharmacy de-identified health data market (Specific to the Five Datasets - Retail Pharmacy as Seller): Dataset Type Estimates & Trend Analysis
                   4.1 Segment Dashboard
                   4.2 U.S. Retail Pharmacy De-identified Health Data Market (Specific to the Five Datasets - Retail Pharmacy as Seller): Dataset Type Analysis, 2024 & 2030 (USD Million)
                   4.3 Retail Pharmacy- Enabled De-Identified Health Datasets: Feature Expectations and Provider Reference Practices (By Dataset Type)
                       4.3.1 Data Integrity
                       4.3.2 Data Recency & Update Frequency
                       4.3.3 Data Breadth & Depth
                       4.3.4 Data Usability
                       4.3.5 Data Longitudinality
                       4.3.6 Value Added Services
                   4.4 Retail Pharmacies as Data Sellers: Score Matrix
                   4.5 Drug Supply Chain Security Data (DSCSA) Market: (Type 1 segment)
                       4.5.1 Drug Supply Chain Security Data (Dscsa) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       4.5.2 DSCSA Data - Market Expectations By Buyer Type: (Type 2 Segment)
                           4.5.2.1 Pharmaceutical Manufacturers Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.5.2.2 Drug Distributors Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.5.2.3 Regulatory Tech Vendors (e.g., TraceLink, LSPedia) Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.5.2.4 Healthcare SaaS Vendors Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.5.2.5 Others (Federal Agencies e.g., FDA, etc.) Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.6 Market Basket Data Market: (Type 1 segment)
                       4.6.1 Market Basket Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       4.6.2 Market Basket Data -Market Expectations By Buyer Type: (Type 2 Segment)
                           4.6.2.1 CPG & Pharma Brands Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.6.2.2 Marketing & AdTech Firms Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.6.2.3 Health Insurers & PBMs Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.6.2.4 Retail Analytics Platforms Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.6.2.5 Others (Data Aggregators (e.g., NielsenIQ, IRI), etc.)) Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.7 Inventory Data Market: (Type 1 segment)
                       4.7.1 Inventory Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       4.7.2 Inventory Data - Market Expectations By Buyer Type: (Type 2 Segment)
                           4.7.2.1 Pharma Manufacturers Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.7.2.2 Distributors/Wholesalers Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.7.2.3 AI/ML Inventory Optimization Vendors Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.7.2.4 Others (Clinical Supply Vendors, etc.) Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.8 Prior Authorization Data Market: (Type 1 segment)
                       4.8.1 Prior Authorization Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       4.8.2 Prior Authorization Data - Market Expectations By Buyer Type: (Type 2 Segment)
                           4.8.2.1 Payers & PBMs Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.8.2.2 Pharma Market Access Teams Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.8.2.3 Health IT Providers Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.8.2.4 Consulting & Policy Firms Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.8.2.5 Others (Advocacy Groups, etc.) Market estimates and forecasts, 2018 - 2030 (USD Million)
                   4.9 Episodic / Pharmacy Rx Claims Data Market: (Type 1 segment)
                       4.9.1 Episodic / Pharmacy Rx Claims Data Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                       4.9.2 Episodic / Pharmacy Rx Claims Data - Market Expectations By Buyer Type: (Type 2 Segment)
                           4.9.2.1 Value-based Payers & ACOs Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.9.2.2 Pharma Outcomes Teams Market Access Teams Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.9.2.3 Real-world Evidence Vendors Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.9.2.4 CMS & Government Organizations Market estimates and forecasts, 2018 - 2030 (USD Million)
                           4.9.2.5 Others (AI/ML Healthtech Firms, etc.) Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Competitive Landscape
                   5.1 Participants’ Overview
                   5.2 Financial Performance
                       5.2.1 Public Companies
                       5.2.2 Private Companies
                   5.3 Competitor Comparison Analysis & Benchmarking
                       5.3.1 CVS HEALTH
                           5.3.1.1 CVS Health- Estimated Pricing Models by Dataset Type
                       5.3.2 WALMART
                           5.3.2.1 Walmart - Estimated Pricing Models by Dataset Type
                       5.3.3 WALGREENS
                           5.3.3.1 Walgreens - Estimated Pricing Models by Dataset Type
                           5.3.3.2 Walgreens Comparative Analysis Across Datasets (vs. Retail/Specialty Peers)
                       5.3.4 THE KROGER CO.
                           5.3.4.1 THE KROGER CO.- Estimated Pricing Models by Dataset Type
                       5.3.5 ALBERTSON
                           5.3.5.1 Albertson - Estimated Pricing Models by Dataset Type
                       5.3.6 UNITEDHEALTH GROUP (OPTUM)
                           5.3.6.1 UNITEDHEALTH GROUP (OPTUM) - Estimated Pricing Models by Dataset Type
                       5.3.7 HUMANA
                           5.3.7.1 HUMANA- Estimated Pricing Models by Dataset Type
                       5.3.8 BRIGHTSPRING HEALTH SERVICES
                           5.3.8.1 BrightSpring Health Services - Estimated Pricing Models by Dataset Type
                       5.3.9 RITE AID CORP
                           5.3.9.1 Rite Aid Corp - Estimated Pricing Models by Dataset Type
                       5.3.10 H‑E‑B LP
                           5.3.10.1 H‑E‑B LP - Estimated Pricing Models by Dataset Type
                       5.3.11 COSTCO WHOLESALE CORPORATION
                           5.3.11.1 COSTCO WHOLESALE CORPORATION- Estimated Pricing Models by Dataset Type
                       5.3.12 CENTENE CORPORATION
                           5.3.12.1 Centene Corporation- Estimated Pricing Models by Dataset Type
                       5.3.13 KONINKLIJKE AHOLD DELHAIZE N.V.
                           5.3.13.1 KONINKLIJKE AHOLD DELHAIZE N.V.- Estimated Pricing Models by Dataset Type
                       5.3.14 AURORA HEALTH CARE (A PART OF ADVOCATE HEALTH)
                           5.3.14.1 Aurora Health Care (a part of Advocate Health).- Estimated Pricing Models by Dataset Type
                       5.3.15 BIG Y FOODS, INC.
                           5.3.15.1 BIG Y FOODS, INC.- Estimated Pricing Models by Dataset Type
                       5.3.16 BROOKSHIRE BROTHERS
                           5.3.16.1 BROOKSHIRE BROTHERS - Estimated Pricing Models by Dataset Type
                       5.3.17 WAKEFERN FOOD CORP.
                           5.3.17.1 Wakefern Food Corp - Estimated Pricing Models by Dataset Type
                       5.3.18 PUBLIX
                           5.3.18.1 PUBLIX - Estimated Pricing Models by Dataset Type
                       5.3.19 CUB (SUBSIDIARY OF UNITED NATURAL FOODS, INC.)
                           5.3.19.1 Cub (subsidiary of United Natural Foods, Inc.) - Estimated Pricing Models by Dataset Type
                   5.4 Participant Categorization
                   5.5 Company Market Share Analysis, 2024 (%)
                       5.5.1 Company Market Share Analysis, By Dscsa Dataset
                       5.5.2 Company Market Share Analysis By Market Basket Data Dataset
                       5.5.3 Company Market Share Analysis By Inventory Dataset
                       5.5.4 Company Market Share Analysis By Episodic Data / Pharmacy Rx Claims Data
                       5.5.5 Company Market Share Analysis By Prior Authorization
                   5.6 Strategy Mapping
                       5.6.1 New Service Launch
                       5.6.2 Partnerships And Collaboration
                       5.6.3 Regional Expansion
                       5.6.4 Others

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Key commercial drivers, its impact, and insights
TABLE 4 State-wise distribution of retail pharmacies in the U.S. (2024)
TABLE 5 Buyer landscape at each dataset level

List of Figures

FIG. 1 U.S. Retail Pharmacy de-identified health data market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 Market formulation & validation
FIG. 8 Market snapshot
FIG. 9 Dataset Type -Segment snapshot
FIG. 10 Competitive landscape snapshot
FIG. 11 Global De-identified Health Data vs U.S. Retail Pharmacy de-identified health data market (Specific to the Five Datasets - Retail Pharmacy as Seller) outlook, 2024, USD Billion
FIG. 12 U.S. Retail Pharmacy de-identified health data market dynamics
FIG. 13 U.S. Retail Pharmacy de-identified health data market : Porter’s five forces analysis
FIG. 14 U.S. Retail Pharmacy de-identified health data market : PESTLE analysis
FIG. 15 U.S. Retail Pharmacy de-identified health data market , Dataset Type Outlook Key Takeaways (USD million)
FIG. 16 U.S. Retail Pharmacy de-identified health data market : Dataset Type Movement Analysis, 2024 & 2030 (USD Million)
FIG. 17 Drug Supply Chain Security Data (DSCSA) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 18 Pharmaceutical Manufacturers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 19 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 20 R&D Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 21 Drug Distributors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 22 Regulatory Tech Vendors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 23 Healthcare SaaS Vendors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 24 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 25 Market Basket Data Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 26 CPG & Pharma Brands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 27 Marketing & AdTech Firms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 28 Health Insurers & PBMs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 29 Retail Analytics Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 30 Others (Data Aggregators (e.g., NielsenIQ, IRI), etc.) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 31 Inventory Data Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 32 Pharma Manufacturers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 33 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 34 R&D Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 35 Distributors/Wholesalers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 36 AI/ML Inventory Optimization Vendors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 37 Others (Clinical Supply Vendors, etc.) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 38 Prior Authorization Data Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 39 Payers & PBMs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 40 Pharma Market Access Teams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 41 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 42 R&D Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 43 Health IT Providers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 44 Consulting & Policy Firms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 45 Others (Advocacy Groups, etc.) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 46 Episodic / Pharmacy Rx Claims Data Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 47 Value-based Payers & ACOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 48 Pharma Outcomes Teams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 49 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 50 R&D Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 51 Real-world Evidence Vendors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 52 Health IT Providers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 53 Others (AI/ML Healthtech Firms, etc.) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
FIG. 54 Company categorization
FIG. 55 Strategic framework